TrialX provides cutting-edge information on new medical treatments and clinical trials in your area.
Meet Dory , your personalized virtual assistant to find clinical trials. Go head, ask her anything. x
All > Ohio Investigators

Roger A. Wood

United States Air Force Medical ...


Wright-Patterson Afb, Ohio - 45433-5529 (937-257-9133)
  • CLINICAL TRIALS 16
  • CONDITIONS32
  • INTERVENTIONS40
  • SINCE2005
Zoledronic Acid in Treating Patients With Metastatic Breast Cancer Metastatic Prostate Cancer or Multiple Myeloma With Bone Involvement

March 2009 - May 2015
Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer

July 2009 - June 2012
Oxaliplatin Leucovorin Calcium and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery

June 2010 - February 2013
Duloxetine in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

April 2008 - January 2010
Bevacizumab and Paclitaxel Paclitaxel Albumin-Stabilized Nanoparticle Formulation or Ixabepilone in Treating Patients With Stage IIIC or Stage IV Breast Cancer

October 2008 - October 2010
Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

April 2009 - August 2011
Doxorubicin Cyclophosphamide and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk Lymph Node-Negative Breast Cancer

November 2007 - November 2013
American Ginseng in Treating Patients With Fatigue Caused by Cancer

October 2008 - October 2010
Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

December 2008 - April 2015
Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

October 2009 - October 2010
Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I Stage II or Stage IIIA Breast Cancer Undergoing Chemotherapy

September 2009 - January 2012
Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I Stage II or Stage III Non-Small Cell Lung Cancer

October 2005 - February 2008
Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer

November 2005 - June 2008
Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy

June 2007 - January 2010
Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery

March 2010 - January 2020
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB Stage II or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery

June 2007 - July 2015
Breast Neoplasms

Colonic Neoplasms

Lung Neoplasms

Lymphoma

Lymphoma, Non-Hodgkin

Adenocarcinoma

Prostatic Neoplasms

Multiple Myeloma

Neoplasms, Plasma Cell

Leukemia

Neoplasms

Neoplasm Metastasis

Hot Flashes

Myelodysplastic Syndromes

Preleukemia

Fatigue

Carcinoma, Non-Small-Cell Lung

Bone Neoplasms

Bone Marrow Diseases

Nausea

Vomiting

Neurotoxicity Syndromes

Precancerous Conditions

Myeloproliferative Disorders

Colorectal Neoplasms

Lymphoma, Large-Cell, Immunoblastic

Peripheral Nervous System Diseases

Demyelinating Diseases

Polyneuropathies

Neurologic Manifestations

Lymphoproliferative Disorders

Osteonecrosis

Gabapentin

Placebo

Immunohistochemistry Staining Method

Laboratory Biomarker Analysis

Zoledronic Acid

Celecoxib

Study Of Socioeconomic And Demographic Variables

Assessment Of Therapy Complications

Paclitaxel

Carboplatin

Bevacizumab

Cisplatin

Docetaxel

Fluorouracil

Leucovorin Calcium

Gemcitabine Hydrochloride

Gene Expression Analysis

Polymorphism Analysis

Cyclophosphamide

Pemetrexed Disodium

Oxaliplatin

Doxorubicin Hydrochloride

Dexamethasone

Polymerase Chain Reaction

Rosuvastatin

Mutation Analysis

Cetuximab

Study Of High Risk Factors

Matrix-Assisted Laser Desorption/Ionization Time Of Flight Mass Spectrometry

Irinotecan Hydrochloride

Ixabepilone

Paclitaxel Albumin-Stabilized Nanoparticle Formulation

Ac Regimen

Duloxetine Hydrochloride

Vinorelbine Ditartrate

American Ginseng

Flaxseed

Acetyl-L-Carnitine Hydrochloride

Chromogenic In Situ Hybridization

Fluorescent Antibody Technique

©2012 Applied Informatics, Inc.
As Seen On:
  • New York Times
  • USA Today
  • bio-itworld logo